Pulse nav.journalClub Tendances Explorer Chercheurs

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Politique de confidentialité

Accueil Explorer nav.journalClub Tendances

⌘+K

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis | Synapse

June 3, 2020Open Access

Efficacité et sécurité de l'abrocitinib chez les patients présentant une dermatite atopique modérée à sévère

Key Points

Key points are not available for this paper at this time.

Abstract

Identifiant ClinicalTrials.gov : NCT03575871.

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Silverberg et al. (Mercredi) ont étudié cette question.

synapsesocial.com/papers/69d8ce83f39dfae3cad17e6f https://doi.org/https://doi.org/10.1001/jamadermatol.2020.1406